VYAFUSER Trademark

Trademark Overview


On Monday, July 1, 2024, a trademark application was filed for VYAFUSER with the United States Patent and Trademark Office. The USPTO has given the VYAFUSER trademark a serial number of 98627518. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, January 23, 2025. This trademark is owned by AbbVie AB. The VYAFUSER trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus, namely, infusion and injection devices for administering drugs; Surgical apparatus and instruments for medical use
vyafuser

General Information


Serial Number98627518
Word MarkVYAFUSER
Filing DateMonday, July 1, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, January 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus, namely, infusion and injection devices for administering drugs; Surgical apparatus and instruments for medical use

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, July 1, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbbVie AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSOLNA 17154
SE

Trademark Events


Event DateEvent Description
Monday, July 1, 2024NEW APPLICATION ENTERED
Tuesday, January 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 21, 2025ASSIGNED TO EXAMINER
Thursday, January 23, 2025NON-FINAL ACTION WRITTEN
Thursday, January 23, 2025NON-FINAL ACTION E-MAILED
Thursday, January 23, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED